{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T16:13:39Z","timestamp":1746116019197,"version":"3.40.4"},"reference-count":75,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina Cl\u00ednica"],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1016\/j.medcli.2013.07.010","type":"journal-article","created":{"date-parts":[[2013,9,21]],"date-time":"2013-09-21T14:17:40Z","timestamp":1379773060000},"page":"453.e1-453.e13","source":"Crossref","is-referenced-by-count":0,"title":["Gu\u00eda de pr\u00e1ctica cl\u00ednica para el tratamiento del s\u00edndrome de Hunter"],"prefix":"10.1016","volume":"141","author":[{"given":"Encarna","family":"Guill\u00e9n-Navarro","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio Javier","family":"Blasco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis G.","family":"Gutierrez-Solana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Luz","family":"Couce","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ram\u00f3n","family":"Cancho-Candela","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pablo","family":"L\u00e1zaro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.medcli.2013.07.010_bib0005","series-title":"The metabolic and molecular basis of inherited disease","first-page":"3421","article-title":"The mucopolysaccharidosis","author":"Neufeld","year":"2001"},{"key":"10.1016\/j.medcli.2013.07.010_bib0010","doi-asserted-by":"crossref","first-page":"e377","DOI":"10.1542\/peds.2007-1350","article-title":"Recognition and diagnosis of mucopolysaccharidosis ii (Hunter syndrome)","volume":"121","author":"Martin","year":"2008","journal-title":"Pediatrics"},{"key":"10.1016\/j.medcli.2013.07.010_bib0015","first-page":"175","article-title":"Guideline for diagnosis, follow-up and treatment of mucopolysaccharidoses type ii or Hunter disease","volume":"109","author":"Guelbert","year":"2011","journal-title":"Arch Argent Pediatr"},{"key":"10.1016\/j.medcli.2013.07.010_bib0020","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.pediatrneurol.2004.10.009","article-title":"Mucopolysaccharidosis type ii in females: Case report and review of literature","volume":"32","author":"Tuschl","year":"2005","journal-title":"Pediatr Neurol"},{"issue":"Supl 2","key":"10.1016\/j.medcli.2013.07.010_bib0025","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.33588\/rn.47S02.2008580","article-title":"World-wide experience in the treatment of mucopolysaccharidosis type ii: The Hunter Outcome Survey (HOS) registry","volume":"47","author":"Del Toro-Riera","year":"2008","journal-title":"Rev Neurol"},{"key":"10.1016\/j.medcli.2013.07.010_bib0030","doi-asserted-by":"crossref","first-page":"E29","DOI":"10.1136\/jmg.37.10.e29","article-title":"MPS II in females: Molecular basis of two different cases","volume":"37","author":"Cudry","year":"2000","journal-title":"J Med Genet"},{"key":"10.1016\/j.medcli.2013.07.010_bib0035","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1002\/ajmg.a.32781","article-title":"Incidence of the mucopolysaccharidoses in Taiwan, 1984-2004","volume":"149A","author":"Lin","year":"2009","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.medcli.2013.07.010_bib0040","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1007\/s10545-005-0112-z","article-title":"Cumulative incidence rates of the mucopolysaccharidoses in Germany","volume":"28","author":"Baehner","year":"2005","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.medcli.2013.07.010_bib0045","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1002\/ajmg.a.20314","article-title":"Incidence of the mucopolysaccharidoses in Western Australia","volume":"123A","author":"Nelson","year":"2003","journal-title":"Am J Med Genet A"},{"issue":"Supl 1","key":"10.1016\/j.medcli.2013.07.010_bib0050","first-page":"S3","article-title":"Clinical aspects of mucopolysaccharidosis type ii","volume":"44","author":"Sanjurjo-Crespo","year":"2007","journal-title":"Rev Neurol"},{"issue":"Supl 1","key":"10.1016\/j.medcli.2013.07.010_bib0055","first-page":"S13","article-title":"Follow-up of patients with Hunter syndrome: The Hunter Outcome Survey (HOS) registry","volume":"44","author":"Del Toro-Riera","year":"2007","journal-title":"Rev Neurol"},{"key":"10.1016\/j.medcli.2013.07.010_bib0060","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s00431-007-0635-4","article-title":"Mucopolysaccharidosis type ii (Hunter syndrome): A clinical review and recommendations for treatment in the era of enzyme replacement therapy","volume":"167","author":"Wraith","year":"2008","journal-title":"Eur J Pediatr"},{"issue":"Supl 2","key":"10.1016\/j.medcli.2013.07.010_bib0065","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.33588\/rn.47S02.2008538","article-title":"Neurological manifestations of Hunter syndrome","volume":"47","author":"Gutierrez-Solana","year":"2008","journal-title":"Rev Neurol"},{"key":"10.1016\/j.medcli.2013.07.010_bib0070","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1007\/s10545-009-1119-7","article-title":"Mortality and cause of death in mucopolysaccharidosis type ii-A historical review based on data from the Hunter Outcome Survey (HOS)","volume":"32","author":"Jones","year":"2009","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.medcli.2013.07.010_bib0075","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/1750-1172-6-72","article-title":"Mucopolysaccharidosis type ii: European recommendations for the diagnosis and multidisciplinary management of a rare disease","volume":"6","author":"Scarpa","year":"2011","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.medcli.2013.07.010_bib0080","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1097\/GIM.0b013e31817701e6","article-title":"Initial report from the Hunter Outcome Survey","volume":"10","author":"Wraith","year":"2008","journal-title":"Genet Med"},{"key":"10.1016\/j.medcli.2013.07.010_bib0085","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/j.1651-2227.2007.00212.x","article-title":"A clinical study of 77 patients with mucopolysaccharidosis type ii","volume":"96","author":"Schwartz","year":"2007","journal-title":"Acta Paediatr Suppl"},{"key":"10.1016\/j.medcli.2013.07.010_bib0090","unstructured":"European Medicines Agency. Ficha t\u00e9cnica Elaprase\u00ae. [consultado 22 Jul 2011]. Disponible en: http:\/\/www.ema.europa.eu\/docs\/es_ES\/document_library\/EPAR_-_Product_Information\/human\/000700\/WC500023008.pdf"},{"key":"10.1016\/j.medcli.2013.07.010_bib0095","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1097\/01.gim.0000232477.37660.fb","article-title":"A phase ii\/iii clinical study of enzyme replacement therapy with idursulfase in mucopolysaccharidosis ii (Hunter syndrome)","volume":"8","author":"Muenzer","year":"2006","journal-title":"Genet Med"},{"key":"10.1016\/j.medcli.2013.07.010_bib0100","unstructured":"Scottish Intercollegiate Guidelines Network. A guideline developers\u2019 handbook: SIGN 50. Edinburgh: SIGN; 2008."},{"key":"10.1016\/j.medcli.2013.07.010_bib0105","unstructured":"Grupo de trabajo sobre GPC. Elaboraci\u00f3n de Gu\u00edas de Pr\u00e1ctica Cl\u00ednica en el Sistema Nacional de Salud. Manual Metodol\u00f3gico. Madrid: Plan Nacional para el SNS del MSC. Instituto Aragon\u00e9s de Ciencias de la Salud-I+CS; 2007. Gu\u00edas de Pr\u00e1ctica Cl\u00ednica en el SNS: I+CS N.o 2006\/0I 2007."},{"key":"10.1016\/j.medcli.2013.07.010_bib0110","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0165-5876(01)00417-7","article-title":"Disordered breathing during sleep in patients with mucopolysaccharidoses","volume":"58","author":"Leighton","year":"2001","journal-title":"Int J Pediatr Otorhinolaryngol"},{"key":"10.1016\/j.medcli.2013.07.010_bib0115","doi-asserted-by":"crossref","first-page":"51","DOI":"10.2143\/AC.60.1.2005049","article-title":"Cardiovascular changes in mucopolysaccharidoses in Taiwan","volume":"60","author":"Chen","year":"2005","journal-title":"Acta Cardiol"},{"key":"10.1016\/j.medcli.2013.07.010_bib0120","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1007\/s00234-004-1215-1","article-title":"Brain MRI findings in patients with mucopolysaccharidosis types i and ii and mild clinical presentation","volume":"46","author":"Matheus","year":"2004","journal-title":"Neuroradiology"},{"key":"10.1016\/j.medcli.2013.07.010_bib0125","doi-asserted-by":"crossref","first-page":"273","DOI":"10.2223\/JPED.1512","article-title":"Prospective study of 11 Brazilian patients with mucopolysaccharidosis ii","volume":"82","author":"Pinto","year":"2006","journal-title":"J Pediatr (Rio J)"},{"key":"10.1016\/j.medcli.2013.07.010_bib0130","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1159\/000113511","article-title":"Otologic manifestations of Hunter syndrome and their relationship with speech development","volume":"13","author":"Cho","year":"2008","journal-title":"Audiol Neurootol"},{"key":"10.1016\/j.medcli.2013.07.010_bib0135","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1111\/j.1468-3083.2007.02203.x","article-title":"Natural history of extensive Mongolian spots in mucopolysaccharidosis type ii (Hunter syndrome): A survey among 52 Japanese patients","volume":"21","author":"Ochiai","year":"2007","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.medcli.2013.07.010_bib0140","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/j.1651-2227.2008.00646.x","article-title":"Magnetic resonance imaging findings in Hunter syndrome","volume":"97","author":"Finn","year":"2008","journal-title":"Acta Paediatr Suppl"},{"key":"10.1016\/j.medcli.2013.07.010_bib0145","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1002\/ajmg.a.32320","article-title":"Mucopolysaccharidoses in Brazil: What happens from birth to biochemical diagnosis?","volume":"146A","author":"Vieira","year":"2008","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.medcli.2013.07.010_bib0150","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1097\/GIM.0b013e3181f6e74d","article-title":"Importance of surgical history in diagnosing mucopolysaccharidosis type ii (Hunter syndrome): Data from the Hunter Outcome Survey","volume":"12","author":"Mendelsohn","year":"2010","journal-title":"Genet Med"},{"key":"10.1016\/j.medcli.2013.07.010_bib0155","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1002\/ajmg.a.34013","article-title":"High prevalence of carpal tunnel syndrome in children with mucopolysaccharidosis type ii (Hunter syndrome)","volume":"155","author":"Kwon","year":"2011","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.medcli.2013.07.010_bib0160","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1097\/GIM.0b013e318206786f","article-title":"Idursulfase treatment of Hunter syndrome in children younger than 6 years: Results from the Hunter Outcome Survey","volume":"13","author":"Muenzer","year":"2011","journal-title":"Genet Med"},{"key":"10.1016\/j.medcli.2013.07.010_bib0165","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.jpeds.2011.01.054","article-title":"Prevalence and characterization of cardiac involvement in Hunter syndrome","volume":"159","author":"Kampmann","year":"2011","journal-title":"J Pediatr"},{"key":"10.1016\/j.medcli.2013.07.010_bib0170","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.jpeds.2011.03.019","article-title":"Early clinical markers of central nervous system involvement in mucopolysaccharidosis type ii","volume":"159","author":"Holt","year":"2011","journal-title":"J Pediatr"},{"key":"10.1016\/j.medcli.2013.07.010_bib0175","doi-asserted-by":"crossref","first-page":"e1258","DOI":"10.1542\/peds.2010-1274","article-title":"Natural progression of neurological disease in mucopolysaccharidosis type ii","volume":"127","author":"Holt","year":"2011","journal-title":"Pediatrics"},{"key":"10.1016\/j.medcli.2013.07.010_bib0180","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1007\/s10545-011-9317-5","article-title":"Brain and spine MRI features of Hunter disease: Frequency, natural evolution and response to therapy","volume":"34","author":"Manara","year":"2011","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.medcli.2013.07.010_bib0185","first-page":"482","article-title":"Diagn\u00f3stico de la mucopolisacaridosis ii (s\u00edndrome de Hunter) en atenci\u00f3n primaria","volume":"64","author":"Baldellou V\u00e1zquez","year":"2006","journal-title":"Acta Pediatr Esp"},{"key":"10.1016\/j.medcli.2013.07.010_bib0190","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1590\/S1415-47572010005000093","article-title":"Mucopolysaccharidosis i, ii, and vi: Brief review and guidelines for treatment","volume":"33","author":"Giugliani","year":"2010","journal-title":"Genet Mol Biol"},{"key":"10.1016\/j.medcli.2013.07.010_bib0195","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1038\/sj.bmt.1702397","article-title":"Unrelated umbilical cord blood transplantation in infancy for mucopolysaccharidosis type iiB (Hunter syndrome) complicated by autoimmune hemolytic anemia","volume":"25","author":"Mullen","year":"2000","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.medcli.2013.07.010_bib0200","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/j.1365-2133.2004.05944.x","article-title":"The effect of haematopoietic stem cell transplant on papules with \u2018pebbly\u2019 appearance in Hunter's syndrome","volume":"151","author":"Ito","year":"2004","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.medcli.2013.07.010_bib0205","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.ymgme.2006.09.001","article-title":"A phase i\/ii clinical trial of enzyme replacement therapy in mucopolysaccharidosis ii (Hunter syndrome)","volume":"90","author":"Muenzer","year":"2007","journal-title":"Mol Genet Metab"},{"issue":"Supl 1","key":"10.1016\/j.medcli.2013.07.010_bib0210","first-page":"S7","article-title":"Clinical study of enzyme replacement therapy with idursulfase","volume":"44","author":"Gutierrez-Solana","year":"2007","journal-title":"Rev Neurol"},{"year":"2007","series-title":"Guidelines for the investigation and management of mucopolysaccharidosis type ii","author":"Vellodi","key":"10.1016\/j.medcli.2013.07.010_bib0215"},{"key":"10.1016\/j.medcli.2013.07.010_bib0220","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/j.1651-2227.2008.00661.x","article-title":"Enzyme replacement therapy with idursulfase in patients with mucopolysaccharidosis type ii","volume":"97","author":"Wraith","year":"2008","journal-title":"Acta Paediatr Suppl"},{"key":"10.1016\/j.medcli.2013.07.010_bib0225","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.ejmg.2008.02.005","article-title":"Early response to idursulfase treatment in a 3 year-old boy affected of Hunter syndrome","volume":"51","author":"Gal\u00e1n-G\u00f3mez","year":"2008","journal-title":"Eur J Med Genet"},{"issue":"Supl 2","key":"10.1016\/j.medcli.2013.07.010_bib0230","first-page":"S15","article-title":"Effectiveness and therapeutic aims of enzyme replacement therapy in mucopolysaccharidosis type ii (Hunter syndrome)","volume":"47","author":"Garc\u00eda Jim\u00e9nez","year":"2008","journal-title":"Rev Neurol"},{"key":"10.1016\/j.medcli.2013.07.010_bib0235","doi-asserted-by":"crossref","first-page":"e1228","DOI":"10.1542\/peds.2008-0999","article-title":"Multidisciplinary management of Hunter syndrome","volume":"124","author":"Muenzer","year":"2009","journal-title":"Pediatrics"},{"key":"10.1016\/j.medcli.2013.07.010_bib0240","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.ymgme.2009.07.015","article-title":"Treatment reduces or stabilizes brain imaging abnormalities in patients with MPS i and ii","volume":"98","author":"Wang","year":"2009","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.medcli.2013.07.010_bib0245","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.ymgme.2009.05.006","article-title":"Localized donor cells in brain of a Hunter disease patient after cord blood stem cell transplantation","volume":"98","author":"Araya","year":"2009","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.medcli.2013.07.010_bib0250","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.jpeds.2008.11.041","article-title":"Bone marrow transplantation in children with Hunter syndrome: Outcome after 7 to 17 years","volume":"154","author":"Guffon","year":"2009","journal-title":"J Pediatr"},{"key":"10.1016\/j.medcli.2013.07.010_bib0255","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.ejmg.2010.07.013","article-title":"First experience of enzyme replacement therapy with idursulfase in Spanish patients with Hunter syndrome under 5 years of age: Case observations from the Hunter Outcome Survey (HOS)","volume":"53","author":"Alcalde-Mart\u00edn","year":"2010","journal-title":"Eur J Med Genet"},{"key":"10.1016\/j.medcli.2013.07.010_bib0260","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.ymgme.2009.08.006","article-title":"Japan Elaprase Treatment (JET) study: Idursulfase enzyme replacement therapy in adult patients with attenuated Hunter syndrome (Mucopolysaccharidosis II, MPS II)","volume":"99","author":"Okuyama","year":"2010","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.medcli.2013.07.010_bib0265","first-page":"S130","article-title":"Effectiveness of idursulfase for Hunter syndrome in European patients enrolled in the Hunter Outcome Survey","volume":"33","author":"Guillen-Navarro","year":"2010","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.medcli.2013.07.010_bib0270","first-page":"S156","article-title":"Hunter syndrome: Enzyme replacement therapy with idursulfase in 3 patients under 5 years of age in Argentina","volume":"33","author":"Amartino","year":"2010","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.medcli.2013.07.010_bib0275","unstructured":"Australian Government. Guidelines for the treatment of Mucopolysaccharidosis Type II (MPSII) disease through the Life Saving Drugs Program. Australia: Australian Government, Department of Health and Ageing; 2010. [consultado 22 Jul 2011]. Disponible en: http:\/\/www.health.gov.au\/internet\/main\/publishing.nsf\/Content\/lsdp-info\/$File\/FINAL%20MPS%20II%20Guidelines%20-%20July%202012.pdf"},{"key":"10.1016\/j.medcli.2013.07.010_bib0280","first-page":"253","article-title":"Long-term enzyme replacement therapy in a severe case of mucopolysaccharidosis type ii (Hunter syndrome)","volume":"15","author":"Papadia","year":"2011","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"10.1016\/j.medcli.2013.07.010_bib0285","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.pediatrneurol.2011.05.010","article-title":"Hunter disease before and during enzyme replacement therapy","volume":"45","author":"Hoffmann","year":"2011","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.medcli.2013.07.010_bib0290","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.mrgentox.2011.02.005","article-title":"DNA damage in leukocytes from pretreatment mucopolysaccharidosis type ii patients; protective effect of enzyme replacement therapy","volume":"721","author":"Filippon","year":"2011","journal-title":"Mutat Res"},{"key":"10.1016\/j.medcli.2013.07.010_bib0295","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1097\/GIM.0b013e3181fea459","article-title":"Long-term, open-labeled extension study of idursulfase in the treatment of Hunter syndrome","volume":"13","author":"Muenzer","year":"2011","journal-title":"Genet Med"},{"key":"10.1016\/j.medcli.2013.07.010_bib0300","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s10545-010-9215-2","article-title":"Effects of enzyme replacement therapy on growth in patients with mucopolysaccharidosis type ii","volume":"34","author":"Schulze-Frenking","year":"2011","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.medcli.2013.07.010_bib0305","doi-asserted-by":"crossref","first-page":"861","DOI":"10.2174\/138920111795542714","article-title":"Mucopolysaccharidosis type ii (Hunter syndrome): Clinical picture and treatment","volume":"12","author":"Beck","year":"2011","journal-title":"Curr Pharm Biotechnol"},{"key":"10.1016\/j.medcli.2013.07.010_bib0310","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.ymgme.2011.02.016","article-title":"Oxidative stress in patients with mucopolysaccharidosis type ii before and during enzyme replacement therapy","volume":"103","author":"Filippon","year":"2011","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.medcli.2013.07.010_bib0315","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1007\/s10545-011-9280-1","article-title":"Treatment of mucopolysaccharidosis type ii (Hunter syndrome) with idursulfase: The relevance of clinical trial end points","volume":"34","author":"Glamuzina","year":"2011","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.medcli.2013.07.010_bib0320","doi-asserted-by":"crossref","first-page":"e42","DOI":"10.1016\/j.rce.2011.01.014","article-title":"[Early response to idursulfase in a 31-year old male patient with Hunter syndrome]","volume":"211","author":"P\u00e9rez-Calvo","year":"2011","journal-title":"Rev Clin Esp"},{"key":"10.1016\/j.medcli.2013.07.010_bib0325","first-page":"CD008185","article-title":"Enzyme replacement therapy with idursulfase for mucopolysaccharidosis type ii (Hunter syndrome)","volume":"11","author":"Da Silva","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.medcli.2013.07.010_bib0330","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s00431-011-1606-3","article-title":"The role of enzyme replacement therapy in severe Hunter syndrome-An expert panel consensus","volume":"171","author":"Muenzer","year":"2012","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.medcli.2013.07.010_bib0335","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1007\/s10545-008-0980-0","article-title":"Home treatment with Elaprase and Naglazyme is safe in patients with mucopolysaccharidoses types ii and vi, respectively","volume":"31","author":"Bagewadi","year":"2008","journal-title":"J Inherit Metab Dis"},{"issue":"Suppl 1","key":"10.1016\/j.medcli.2013.07.010_bib0340","first-page":"S100","article-title":"Management of infusion-related reactions to enzyme replacement therapy in a cohort of patients with mucopolysaccharidosis disorders","volume":"47","author":"Miebach","year":"2009","journal-title":"Int J Clin Pharmacol Ther"},{"key":"10.1016\/j.medcli.2013.07.010_bib0345","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.ymgme.2009.04.007","article-title":"Home infusion therapy is safe and enhances compliance in patients with mucopolysaccharidoses","volume":"97","author":"Burton","year":"2009","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.medcli.2013.07.010_bib0350","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.ymgme.2010.06.011","article-title":"Home treatment with intravenous enzyme replacement therapy with idursulfase for mucopolysaccharidosis type II - Data from the Hunter Outcome Survey","volume":"101","author":"Burton","year":"2010","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.medcli.2013.07.010_bib0355","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.ymgme.2011.02.018","article-title":"Incidence and timing of infusion-related reactions in patients with mucopolysaccharidosis type ii (Hunter syndrome) on idursulfase therapy in the real-world setting: A perspective from the Hunter Outcome Survey (HOS)","volume":"103","author":"Burton","year":"2011","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.medcli.2013.07.010_bib0360","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1023\/A:1005525931994","article-title":"Long-term follow-up following bone marrow transplantation for Hunter disease","volume":"22","author":"Vellodi","year":"1999","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.medcli.2013.07.010_bib0365","first-page":"49","article-title":"Prenatal diagnosis and genetic counseling of mucopolysaccharidosis type ii (Hunter syndrome)","volume":"18","author":"Chen","year":"2007","journal-title":"Genet Couns"},{"key":"10.1016\/j.medcli.2013.07.010_bib0370","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1002\/pd.2786","article-title":"Preventing mucopolysaccharidosis type ii (Hunter syndrome): PGD and establishing a Hunter (46, XX) stem cell line","volume":"31","author":"Altarescu","year":"2011","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.medcli.2013.07.010_bib0375","series-title":"Asesoramiento gen\u00e9tico en la pr\u00e1ctica m\u00e9dica","first-page":"395","article-title":"Gen\u00e9tica de la reproducci\u00f3n","author":"Guillen-Navarro","year":"2012"}],"container-title":["Medicina Cl\u00ednica"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025775313005320?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025775313005320?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T14:48:40Z","timestamp":1746024520000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025775313005320"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11]]},"references-count":75,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2013,11]]}},"alternative-id":["S0025775313005320"],"URL":"https:\/\/doi.org\/10.1016\/j.medcli.2013.07.010","relation":{},"ISSN":["0025-7753"],"issn-type":[{"type":"print","value":"0025-7753"}],"subject":[],"published":{"date-parts":[[2013,11]]}}}